The approach was further developed for breast cancer studies comparing imaging mass spectra of peptide peaks between fibroblastic IHC stains (αSMA, FAP, P4HA3) and a control nonstained tissue of breast tumor. The gene discussed is ACTA1; the disease is breast carcinoma.